Hims Soars as It Partners with Novo Nordisk to Offer Wegovy: A Turning Point in Telehealth Weight-Loss Care In a move that could reshape the future of telehealth-driven chronic care, Hims & Hers Health (NASDAQ: HIMS) announced a groundbreaking partnership with global pharmaceutical leader Novo Nordisk to distribute the blockbuster weight-loss drug, Wegovy, through its digital health platform. Th..
